87 related articles for article (PubMed ID: 30318772)
1. Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer.
Shepshelovich D; Townsend AR; Espin-Garcia O; Latifovic L; O'Callaghan CJ; Jonker DJ; Tu D; Chen E; Morgen E; Price TJ; Shapiro J; Siu LL; Kubo M; Dobrovic A; Ratain MJ; Xu W; Mushiroda T; Liu G
Cancer Med; 2018 Nov; 7(11):5478-5487. PubMed ID: 30318772
[TBL] [Abstract][Full Text] [Related]
2. Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.
Lee YH; Song GG
Pharmacogenomics J; 2023 Nov; 23(6):210-216. PubMed ID: 37149714
[TBL] [Abstract][Full Text] [Related]
3. Correlations of FCGR2A 131R/H and FCGR3A 158V/F Polymorphisms with the Susceptibility of Peri-implantitis in Chinese Han Population.
Li P; Chen B; Zhao L; Yang F; Zhang Z; Cao Y; Hu Y
Mol Biotechnol; 2024 May; ():. PubMed ID: 38771420
[TBL] [Abstract][Full Text] [Related]
4. To Determine the Genotyping of Fc-gamma Receptor FCGR2A Polymorphism as Genetic Susceptibility to Neonatal Sepsis: A Study from a Tertiary Center of North India.
Chowdhary S; Sharma K; Ashish A; Yadav AK; Panigrahi P; Mishra A; Kumar D; Singh R
J Indian Assoc Pediatr Surg; 2022; 27(6):718-722. PubMed ID: 36714470
[TBL] [Abstract][Full Text] [Related]
5. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A.
Eckhardt CL; Astermark J; Nagelkerke SQ; Geissler J; Tanck MW; Peters M; Fijnvandraat K; Kuijpers TW
J Thromb Haemost; 2014 Aug; 12(8):1294-301. PubMed ID: 24916518
[TBL] [Abstract][Full Text] [Related]
6. Differential FCGR2A and FCGR3A Alleles/Genotypes in Pemphigus Vulgaris and Pemphigus Foliaceus in Southeastern Brazil.
Valei Lopes de Oliveira E; Tremeschin de Almeida Vieira F; de Souza Pinhel MA; Gripp AC; Marzocchi-Machado CM; Donadi EA; Roselino AM
J Invest Dermatol; 2024 Mar; 144(3):702-705.e1. PubMed ID: 37806444
[No Abstract] [Full Text] [Related]
7. The association of healthcare contact days with physical function and survival in CCTG/AGITG CO.17.
Gupta A; O'Callaghan CJ; Zhu L; Jonker DJ; Wong RPW; Colwell B; Moore MJ; Karapetis CS; Tebbutt NC; Shapiro JD; Tu D; Booth CM
J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38656931
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
Amin A; Plimack ER; Ernstoff MS; Lewis LD; Bauer TM; McDermott DF; Carducci M; Kollmannsberger C; Rini BI; Heng DYC; Knox J; Voss MH; Spratlin J; Berghorn E; Yang L; Hammers HJ
J Immunother Cancer; 2018 Oct; 6(1):109. PubMed ID: 30348216
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J
J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283
[TBL] [Abstract][Full Text] [Related]
10. Natural Products Treat Colorectal Cancer by Regulating miRNA.
Guo S; Chen M; Li S; Geng Z; Jin Y; Liu D
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631037
[TBL] [Abstract][Full Text] [Related]
11. Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions.
Deng Y; Tu D; O'Callaghan CJ; Liu G; Xu W
Stat Methods Med Res; 2023 Aug; 32(8):1543-1558. PubMed ID: 37338962
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC.
Scarabel L; Bignucolo A; Toffoli G; Cecchin E; De Mattia E
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432658
[TBL] [Abstract][Full Text] [Related]
13. Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies.
Mata-Molanes JJ; Rebollo-Liceaga J; Martínez-Navarro EM; Manzano RG; Brugarolas A; Juan M; Sureda M
Front Oncol; 2022; 12():926289. PubMed ID: 35814459
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.
Klinghammer K; Fayette J; Kawecki A; Dietz A; Schafhausen P; Folprecht G; Rottey S; Debourdeau P; Lavernia J; Jacobs A; Ahrens-Fath I; Dietrich B; Baumeister H; Zurlo A; Ochsenreither S; Keilholz U
ESMO Open; 2021 Oct; 6(5):100242. PubMed ID: 34482179
[TBL] [Abstract][Full Text] [Related]
15.
Dai Y; Chen W; Huang J; Cui T
Biomed Res Int; 2021; 2021():8874578. PubMed ID: 34285919
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies.
Alcaide EG; Krishnarajah S; Junker F
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33924183
[TBL] [Abstract][Full Text] [Related]
17. Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions.
Tang Y; Cao Y
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800976
[TBL] [Abstract][Full Text] [Related]
18. The Current Landscape of Antibody-based Therapies in Solid Malignancies.
Shah A; Rauth S; Aithal A; Kaur S; Ganguly K; Orzechowski C; Varshney GC; Jain M; Batra SK
Theranostics; 2021; 11(3):1493-1512. PubMed ID: 33391547
[TBL] [Abstract][Full Text] [Related]
19. Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival.
Qian D; Liu H; Zhao L; Wang X; Luo S; Moorman PG; Patz EF; Su L; Shen S; Christiani DC; Wei Q
Transl Lung Cancer Res; 2020 Jun; 9(3):575-586. PubMed ID: 32676321
[TBL] [Abstract][Full Text] [Related]
20. Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor.
Liu Y; Zhou Y; Huang KH; Fang X; Li Y; Wang F; An L; Chen Q; Zhang Y; Shi A; Yu S; Zhang J
Cell Prolif; 2020 Aug; 53(8):e12858. PubMed ID: 32592435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
